Israel Capital Canada Corp. focuses on the development and commercialization of a frequency emitter. Its frequency emitter delivers a special package of frequencies for the health and wellness market to target Lyme disease within North America. The company is based in Vancouver, Canada.
Research context
Israel Capital Canada Corp appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Financial Services
- Industry
- Shell Companies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Israel Capital Canada Corp is currently in a long term downtrend where the price is trading 0.0% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 0.0.
Based on the above factors, Israel Capital Canada Corp gets an overall score of 1/5.